CompletedNot Applicable

A Survey Collecting Data on Adult Height in Patients With Achondroplasia Treated With Somatropin

Japan81 participantsStarted 2012-11-22

Plain-language summary

This study is conducted in Japan. The aim of the study is to evaluate the efficacy of somatropin (Norditropin®) on adult height (cm) in patients with achondroplasia / hypochondroplasia enrolled in the GH-1941 study (NCT01516229).

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients who were enrolled in the GH-1941 study (1997 to 2006) and expected to theoretically reach the adult height within the study period

What they're measuring

To collect change data of adult height (cm) of patients treated with Norditropin® and evaluate the long-term efficacy

Timeframe: At year 1, 2, 3, 4, and 5 after the patient has reached adult height or is 18 of age

Trial details

NCT IDNCT01435629

SponsorNovo Nordisk A/S

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

Primary completion2015-12-04

View on ClinicalTrials.gov More Genetic Disorder trials